Treatment of phospholipase A2 receptor associated membranous nephropathy with obinutuzumab: a report of ten cases with a literature review
Objective To explore the efficacy and safety of obinutuzumab (OBZ) for phospholipase A2 receptor（PLA2R）-associated membranous nephropathy (MN) with an intermediate-to-high risk of progression. MethodsFrom January 2022 to November 2022, ten patients with a diagnosis of primary membranous nephropathy...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Editorial Department of Journal of Clinical Nephrology,
2024-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!